Alpha 2.0
Login Register
» Articles » PMID: 4249736

G-M1-gangliosidosis. Correlation of Clinical and Biochemical Data

Overview
Journal Arch Neurol
Specialty Neurology
Date 1971 Jan 1
PMID 4249736
Citations 10
Authors
Y Suzuki
A C Crocker
K Suzuki
Affiliations
Soon will be listed here.
Citing Articles

Lysosomal storage diseases.

Ferreira C, Gahl W Transl Sci Rare Dis. 2017; 2(1-2):1-71.

PMID: 29152458 PMC: 5685203. DOI: 10.3233/TRD-160005.

Sustained normalization of neurological disease after intracranial gene therapy in a feline model.

McCurdy V, Johnson A, Gray-Edwards H, Randle A, Brunson B, Morrison N Sci Transl Med. 2014; 6(231):231ra48.

PMID: 24718858 PMC: 4412602. DOI: 10.1126/scitranslmed.3007733.

Chaperone therapy for neuronopathic lysosomal diseases: competitive inhibitors as chemical chaperones for enhancement of mutant enzyme activities.

Suzuki Y, Ogawa S, Sakakibara Y Perspect Medicin Chem. 2009; 3:7-19.

PMID: 19812739 PMC: 2754921. DOI: 10.4137/pmc.s2332.

A new form of ovine GM1-gangliosidosis.

Skelly B, Jeffrey M, Franklin R, Winchester B Acta Neuropathol. 1995; 89(4):374-9.

PMID: 7610770 DOI: 10.1007/BF00309632.

Clinical and enzymatic variations in G M1 generalized gangliosidosis.

Singer H, Schafer I Am J Hum Genet. 1972; 24(4):454-63.

PMID: 5031983 PMC: 1762258.